Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 9, 2013, Pages 1018-1026

  Rydén, Anna ^a   Denison, Hans ^a   Karlsson, Maria ^a   Vakil, Nimish ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Gastroesophageal reflux; Proton pump inhibitors; Questionnaires

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL (TOPIC); CONSENSUS; CONSENSUS DEVELOPMENT; CONSTRUCT VALIDITY; CONTENT VALIDITY; CONVERGENT VALIDITY; CORRELATION ANALYSIS; COUGHING; DISCRIMINANT VALIDITY; DYSPHAGIA; FEMALE; GASTROESOPHAGEAL REFLUX; HOARSENESS; HUMAN; INSTRUMENT VALIDATION; INTERNAL CONSISTENCY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; RECALL; SELF REPORT; SYMPTOM ASSESSMENT; TEST RETEST RELIABILITY; TREATMENT OUTCOME; TREATMENT RESPONSE; VALIDATION STUDY;

ADULT; COUGH; DEGLUTITION DISORDERS; ERUCTATION; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HOARSENESS; HUMANS; LARYNGOPHARYNGEAL REFLUX; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 84882998210     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.822544     Document Type: Article

References (28)

1. El-Serag H, Becher A, Jones R. Systematic review: Persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther 2010;32:720-37
2. Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: Proton-pump inhibitor failure in gastro-oesophageal reflux disease-where next? Aliment Pharmacol Ther 2005;22: 79-94 (Pubitemid 41039696)
3. Lehmann A. New pharmacological concepts in the treatment of gastro-oesophageal reflux disease. Eur Gastroenterol Hepatol Rev 2010;6:100-4
4. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2012;108:308-28
5. Patient-reported outcome measures: Use in medical product development to support labeling claims Rockville, USA: Food and Drug Administration, 2009. Available from http: //www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/ Guidances/UCM193282.pdf. Accessed 29 January 2013
6. Shaw M, Dent J, Beebe T, Junghard O, Wiklund I, Lind T, et al. The Reflux Disease Questionnaire: A measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes 2008;6:31
7. Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001; 96:52-7 (Pubitemid 32104807)
8. Vakil N, Bjorck K, Denison H, Halling K, Karlsson M, Paty J, et al. Validation of the reflux symptom questionnaire electronic diary in partial responders to proton pump inhibitor therapy. Clin Transl Gastroenterol 2012;3:e7
9. Svedlund J, Sjodin I, Dotevall G. GSRS-A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33:129-34 (Pubitemid 18054672)
10. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046-52
11. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77:371-83 (Pubitemid 34260746)
12. Robinson M, Sahba B, Avner D, Jhala N, Greski-Rose PA, Jennings DE. A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group. Aliment Pharmacol Ther 1995;9:25-31
13. Fayers PM, Machin D. Quality of life: Assessment, analysis and interpretation. edition. Wiley; Chichester: 2000
14. Fleiss JL. The design and analysis of clinical experiments. Wiley classics library edition. Wiley; New York: 1999
15. Vakil NB, Halling K, Becher A, Rydén A. Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms. Eur J Gastroenterol Hepatol 2013;25:2-14
16. Veldhuyzen van Zanten S, Armstrong D, Barkun A, Junghard O, White RJ, Wiklund IK. Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: Further psychometric validation of the Reflux Disease Questionnaire. Aliment Pharmacol Ther 2007;25:1087-97 (Pubitemid 46587686)
17. Bredenoord AJ, Weusten BL, Timmer R, Smout AJ. Air swallowing, belching, and reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol 2006;101:1721-6 (Pubitemid 44166577)
18. Kessing BF, Bredenoord AJ, Velosa M, Smout AJ. Supragastric belches are the main determinants of troublesome belching symptoms in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2012; Epub ahead of print
19. Smith JA, Decalmer S, Kelsall A, McGuinness K, Jones H, Galloway S, et al. Acoustic cough-reflux associations in chronic cough: Potential triggers and mechanisms. Gastroenterology 2010;139:754-62
20. Liu JY, Woloshin S, Laycock WS, Rothstein RI, Finlayson SR, Schwartz LM. Symptoms and treatment burden of gastroesophageal reflux disease: Validating the GERD assessment scales. Arch Intern Med 2004;164: 2058-64 (Pubitemid 39390565)
21. Thompson SK, Cai W, Jamieson GG, Zhang AY, Myers JC, Parr ZE, et al. Recurrent symptoms after fundoplication with a negative pHstudy-recurrent reflux or functional heartburn? J Gastrointest Surg 2009;13:54-60
22. Kahrilas PJ, Howden CW, Hughes N, Molloy-Bland M. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease. Chest 2013; 143:605-12
23. Vaezi M. Chronic cough and gastroesophageal reflux disease: How do we establish a causal link? Chest 2013;143: 587-90
24. Heading RC, Monnikes H, Tholen A, Schmitt H. Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: A prospective pragmatic trial using pantoprazole. BMC Gastroenterol 2011;11:52
25. Bytzer P. Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients. Am J Gastroenterol 2003;98:S31-9 (Pubitemid 36348513)
26. Bytzer P, van Zanten SV, Mattsson H, Wernersson B. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis-A post hoc analysis of 5796 patients. Aliment Pharmacol Ther 2012;36:635-43
27. Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease (GERD)-A global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20
28. Dent J, Kahrilas PJ, Vakil N, Veldhuyzen van Zanten S, Bytzer P, Delaney B, et al. Clinical trial design in adult reflux disease-A methodological workshop. Aliment Pharmacol Ther 2008;28:107-26 (Pubitemid 351782809)